Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease
Abstract Background Inflammatory bowel disease (IBD) is a rare adverse effect linked to secukinumab, with limited clinical data available. This study aimed to analyze the clinical features of secukinumab-induced IBD and to offer recommendations for the careful administration of secukinumab. Methods...
Saved in:
Main Authors: | Ronghui Li, Haibo Lei, Chunjiang Wang, Xiang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-025-02295-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01) -
Modern Approaches in the Morphological Diagnosis of Inflammatory Bowel Diseases
by: A. S. Tertychnyy, et al.
Published: (2022-08-01) -
The Influence of Physical Activity on Inflammatory Markers, Intestinal Microbiota Composition and Disease Activity in Inflammatory Bowel Disease
by: Paulina Jakubczyk, et al.
Published: (2025-01-01) -
Substantiation of application and estimation of efficacy of probiotics at inflammatory bowel diseases
by: Ye. A. Poluektova, et al.
Published: (2015-05-01) -
Inflammatory Bowel Disease and Statins
by: V. V. Genkel, et al.
Published: (2020-04-01)